e-tender for procurement of drug items under table-a, for two years from the date of aoc , aceclofenac tab ip 100mg , aciclovir tab. i.p. 400 mg , adenosine inj. u.s.p. 3 mg / ml in 2 ml. , albendazole oral suspension u.s.p. 400mg./10ml , albendazole tab. i.p. 400 mg. , alfuzosin tab 10mg , alprazolam tab. i.p. 0.50mg. , alprazolam tab.i.p. 0.25mg. , amikacin inj. i.p. 500mg / 2ml.vial , amitriptyline hcl tab. i.p. 25mg. , amlodipine tablet i.p. 5mg , amoxicillin 250 mg and clavulanic acid 50 mg inj i.p. , amoxycillin 1 g with clavulinic acid 200 mg inj. , ampicillin sodium inj. i.p. 500mg / vial. , anti rabies immunoglobulin-equine derived higlhy purified and enzyme digested having a potency of not less than 300 i.u./ml.-5ml.vial. , artesunate inj. combi pack containing sodium bi-carbonate inj. 5% w/v in 1ml ampule, sodium chloride inj. 0.9% in 5ml ampule & artesunate inj. 60 mg vial , atorvastatin 10mg tab. , atorvastatin 40mg tab. , atracurium besylate inj.u.s.p. 25 mg/ 2.5 ml amp. , baclofen tab ip 10 mg , bedaquiline (bdq) 100mg tab , bicalutamide tab ip 50 mg , bisacodyl tab.i.p. 5mg. , bleomycin sulphate inj.i.p. 15 units. (powder for reconstitution) /vial. , budesonide inhaler 100mcg /mdi (in maximum of 200 mdi pack) , calcium carbonate tab 500 mg , carbamazepine i.p. 200 mg tab. , carboplatin inj. 150 mg. , carboprost tromethamine inj.u.s.p. 250mcg./ml. , cefepime inj. 1 gm./vial , cefixime tab 100 mg (dispersible) , cefixime tab ip 200mg , cephalexin tab/cap 250 mg , cetirizine i.p. 10 mg tabs. , cetirizine syrup 5mg/5ml , chlorhexidine gluconate mouth wash 0.2% w/v , cinnarizine tab ip 25 mg , cisplatin inj. 50mg./vial , cisplatin inj.i.p. 10mg./vial. , clarithromycin 500 mg tab , clobazam tab ip 10 mg , clobetasol propionate 0.05% cream- 15 gm tube , clomipramine tab. 25 mg , clotrimazole cream i.p. 1% , comb. gastric antacid susp.(al.+ mg. hydroxide) (total salt being not less than 500mg/5ml.) , daunorubicin inj 20 mg/vial , deferasirox 500mg dispersable tab. , diazepam inj.i.p. 10 mg/2ml ampoule , diclofenac sodium 1% gel - 30gm tube , divalproex sodium tab. 500 mg , dobutamine inj. 50mg /ml in 5ml amp. , domperidone tab.i.p. 10 mg , dopamine hcl inj.b.p 40mg/ml- 5ml amp. , drotaverine hcl inj. 40mg / 2ml amp. , eltrombopag tab 50mg , enoxapiran sodium inj. 40 mg in 0.4 ml. , entecavir 0.5mg tab , escitalopram tab. 10 mg , etoposide cap. 50 mg. , etoposide inj.i.p. 20mg./ml. in 5ml. vial / amp , febuxostat tab. 40 mg , fluconazole 150 mg tab/cap. i.p. , flunarizine ip 10 mg tab , fluoxetine tab 20 mg , formoterol 6mcg + budesonide 200mcg / puff inhaler i.p with free spacer (in maximum of 200 mdi pack) , gabapentin tab/cap ip 300 mg , haloperidol tab. i.p. 5mg. , hydroxychloroquine tab 200mg , ibuprofen i.p. 200 mg tab. , ibuprofen i.p. 400 mg tab. , imatinib mesylate 100 mg. tab/cap , imatinib mesylate 400 mg. tab/cap , imipenem 500 mg + cilastatin 500 mg injection , iron folic acid syrup containing ferrous sulphate equivalent to elemental iron 20mg + folic acid 0.1 mg/ml , labetalol 100 mg. tab. , lactulose sol. usp 10gm / 15 ml , lenalidomide caps 5mg , leucovorin inj. 50 mg. / 5ml. vial / amp. , levetiracetam ip tab 250 mg , levetiracetam ip tab 500 mg , linezolid 600 mg tab. , losartan potassium tab.50 mg , methyl prednisolone inj. 1 g / vial. , methyl prednisolone inj. 500 mg/vial. , metoprolol tab. 25 mg (controlled release) , metoprolol tab. 50 mg (controlled release) , midazolam inj.b.p. 5 mg /ml in 1ml amp. , mifepristone 200 mg tab. , montelukast tab ip 10mg , moxifloxacin 0.5% w/v eye drop , moxifloxacin 400mg tab. , mupirocin 2% oint. , nilotinib 200 mg tab. , noradrenaline inj. i.p. 2 mg /ml - 2 ml amp. , o.r.s i.p. 96 as powder for reconstitution,cont.:sod. chloride 2.6gm.,dextrose (monohydrade 14.85 gms,pot.cl 1.5 & pck sod.citrate 2.9gms (total 21.85 per packet). , ofloxacin tab.i.p. 200 mg , olanzepine tab.i.p. 5mg. , ondansetron 4 mg tab. , ondansetron syrup/ oral solution 2mg/5ml , oseltamivir capsules ip 75mg , pantoprazole 40 mg. inj. , paracetamol 250 mg. tab. , pemetrexed 500 mg inj./ vial , pentazocine hcl. inj.i.p. 30 mg/ 1ml amps. , permethrin cream 5% w/w , phenobarbitone sodium inj. i.p.200 mg in 1ml amp. , phenytoin sodium i.p. 100 mg tab. , pioglitazone 15 mg tab , piperacillin 1gm + inj. tazobactum (125 mg)/vial , povidone iodine oint. 5% , povidone iodine solution i.p 5% w/v , pregabalin ip 75 mg tab/cap , pretomanid 200 mg tab , promethazine oral soln. i.p. 5mg / 5 ml , salbutamol syrup i.p. 2mg./5ml. , salbutamol tab.i.p. 4mg (scored) , sertraline tab. 50 mg , silver sulphadiazine cream 1% , snake anti venom serum i.p.(lyophilised) reconstituted (10ml) neutralizing venoms of cobra, common krait, russells viper, saw scaled viper , sodium chloride & dextrose injection i.p. (form, fill & seal process) , sodium chloride inj. ip 0.9% w/v 100 ml ffs , sodium valproate 200 mg tab. , sulphamethoxazole 200 mg + trimethoprim 40 mg /5ml oral suspension , sulphamethoxazole 800mg + trimethoprim 160mg tablet i.p , tacrolimus cap 0.5mg , tacrolimus cap 1 mg , tamsulosin pr tab/cap 0.4 mg , telmisartan tab 80 mg , thalidomide caps 50mg , theophylline 23 mg with etophylline 77 mg tab. , timolol maleate eye drop i.p. 0.5% w/v , tobramycin eye drops 0.3%w/v in 5ml , tranexamic acid inj. 100 mg / 1ml in 5 ml amp. , trihexyphenidyl hcl tablet i.p 2 mg , valganciclovir tab. 450 mg tab. , vecuronium bromide inj. 10mg / vial , vit d3 oral drop 400 iu/ ml , vitamin b.complex tab.nfi- iii (prophylactic) , voglibose 0.3 mg tab , xylometazoline 0.1% nasal drop , zinc sulphate 20 mg. (dispersable) tab. , important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender. 2. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period. 3. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b)in case of sole manufacturer/importer (i.e. proprietary in nature). 4. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis. 5. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f(y), dated 07.06.2022 issued from finance department audit branch (group t).